𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck

✍ Scribed by Masato Fujii; Mamoru Tsukuda; Bunsuke Satake; Akira Kubota; Akinori Kida; Naoyuki Kohno; Kenji Okami; Yukio Inuyama

Publisher
Springer
Year
2004
Tongue
English
Weight
428 KB
Volume
9
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase I and initial phase II results fro
Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck
✍ David L. Schwartz; R. Bruce Montgomery; Bevan Yueh; Michael Donahue; Yoshimi Anz πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 113 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The current Phase I/II study assessed induction docetaxel/carboplatin given weekly for 4 weeks, followed by weekly docetaxel/carboplatin and concomitant boost radiotherapy (CB‐XRT) for locally advanced head and neck squamous cell carcinoma. ## METHODS Twenty patients wi

Radiotherapy for basaloid squamous cell
Radiotherapy for basaloid squamous cell carcinoma of the head and neck
✍ Dr. James M. Larner; Dr. Ronald H. Malcolm; Dr. Stacey E. Mills; Dr. Henry F. Fr πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 451 KB πŸ‘ 2 views

Basaloid squamous cell carcinoma (BSCC) of the head and neck is a recently described high-grade variant of squamous cell carcinoma. It is a biologically virulent neoplasm with a propensity for nodal, as well as systemic, metastases. Because of the limited number of published reports, we reviewed dat

Pilot trial of concomitant chemotherapy
Pilot trial of concomitant chemotherapy with paclitaxel and split-course radiotherapy for very advanced squamous cell carcinoma of head and neck
✍ Olavo Feher; Sandro J. Martins; Candice A. Lima; JoΓ£o V. Salvajoli; Andrew J. Si πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 2 views

## Abstract ## Purpose The combination of chemotherapy and irradiation is considered the standard of care for the treatment of advanced squamous cell carcinoma of head and neck (SCCHN). Paclitaxel has shown a single‐agent activity in SCCHN. Besides, this drug is a promising radiosensitizer for som